Monograph
C10AB05 - Fenofibrate |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate of CYP 3A4. No data pointing to CYP-inducing properties.
Chemical description
Prodrug to the lipid lowering agent phenofibrate acid. Dose 200 mg/d. Metabolized by CYP 3A4. No indications of CYP-induction.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
References
Tradenames
Fenogal 
Fenofibraat · Fenofibrate · Fenogal Lidose · Fenosup Lidose · Lipanthyl 
Fenofibrato · Secalip · Secalip Supra 
Fenobrat · Fenoswiss · Fenoswiss Forte · Lipidil · Lipidil Supra 
Fenofibrato · Fulcro · Fulcrosupra · Liperial · Lipofene · Lipsin 
Fenofibrat · Lipanthyl · Lipantil · Lipivim · Lipofib 
Lipanthyl 
Fenofibrate · Fenofibrate micronised · Fenogal · Lipantil · Supralip 
Fenofibrat · Fenolip · Lipanthyl · Lipantil · Lipofene · Thylip 
Apo-Feno · Biofibrat · Fenardin · Fibralipid · Grofibrat · Lipanthyl 
Fegenor · Fenofibrate · Fenogal Lidose · Lipanthyl 
Lipanthyl 
Lipanthyl · Lipivim 
Lipanthyl 
Lipanthyl 
Fenolip · Lipanthyl · Zyglip 
Fenofibrat · Fenolip · Katalip · Lipsana